Arpimune ME is a drug belonging to the immunosuppressive group. It works by reducing the activity of the immune system to prevent rejection of transplanted organs after kidney, liver, or heart transplants. It is also used in some autoimmune diseases in which the body attacks its own tissues, such as arthritis, psoriasis, and chronic eye infections. It helps improve the patient's condition by controlling excessive immune responses.
This treatment represents an essential step in immunosuppression plans, as
Arpimune ME works to achieve a delicate balance between protecting the body from rejection of the transplanted organ and reducing complications that may be caused by an overactive immune system. It is recommended to use it under strict medical supervision, adhere to the prescribed dosage, and conduct periodic tests to monitor kidney and liver function and blood pressure to ensure the effectiveness of the treatment and maintain patient safety.